When high-grade gliomas recur, patients, their families, and clinicians face difficult medical decisions. There is no curable treatment, and the treatment options all come with a risk of com-plications and adverse effects. The patients are often cognitively affected, and they need tailored decision support. The objective of this study was to develop a patient decision aid (PtDA) targeted at patients with recurrent high-grade gliomas. Based on existing knowledge and the International Patient Decision Aids Standards, the PtDA was developed through an iterative process. The PtDA was alpha-tested by potential users to assess its acceptability and usability. The development team comprised three clinicians, two patients, two family members, and a researcher. The fifth version of the PtDA was submitted to the alpha test. Eleven patients, nine family members, and eleven clinicians assessed the PtDA and found it acceptable. Three changes were made during the alpha test. Most participants perceived the PtDA to prepare patients for decision making and improve consultations. The involvement of potential users was emphasized during the development and alpha test process. The PtDA was assessed as useful and acceptable by patients, family members, and clinicians in the decision-making situation of recurrent high-grade glioma.

Original languageEnglish
Article number7396
JournalInternational Journal of Environmental Research and Public Health
Issue number12
Number of pages17
Publication statusPublished - 1. Jun 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.


  • decision support
  • family involvement
  • high-grade glioma
  • neuro-oncology
  • patient decision aids
  • patient involvement
  • shared decision making


Dive into the research topics of 'Development of a Patient Decision Aid to Support Shared Decision Making for Patients with Recurrent High-Grade Glioma'. Together they form a unique fingerprint.

Cite this